Limitations of 18F-2-deoxy-d-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management

Annals of Thoracic Surgery

Volumn 99, Issue 2, 2015, Pages 414-420

  Kim, Min P ^a,b,c   Correa, Arlene M ^a   Hofstetter, Wayne ^a   Mehran, Reza ^a   Rice, David C ^a   Roth, Jack A ^a   Vaporciyan, Ara A ^a   Walsh, Garrett L ^a   Erasmus, Jeremy J ^a   Swisher, Stephen G ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; LOBECTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSTIC USE; EVALUATION STUDY; LUNG NEOPLASMS; MORTALITY; PATHOLOGY; SCINTISCANNING; SURVIVAL RATE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84921861946     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2014.09.023     Document Type: Article

References (24)

1. J.D. Bradley, I. El Naqa, R.E. Drzymala, M. Trovo, G. Jones, and M.D. Denning Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant Int J Radiat Oncol Biol Phys 77 2010 1146 1150
2. E.S. Alexander, and D.E. Dupuy Lung cancer ablation: technologies and techniques Semin Intervent Radiol 30 2013 141 150
3. Y.H. Choe, S.R. Kim, and K.S. Lee The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer Eur J Cancer 45 2009 1773 1779
4. S. Shin, H.K. Kim, Y.S. Choi, K. Kim, J. Kim, and Y.M. Shim Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer Ann Thorac Surg 96 2013 969 975 discussion 975-6
5. C.E. Reed, D.H. Harpole, and K.E. Posther Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer J Thorac Cardiovasc Surg 126 2003 1943 1951
6. A. Bille, E. Pelosi, and A. Skanjeti Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography Eur J Cardiothorac Surg 36 2009 440 445
7. N. Ose, N. Sawabata, and M. Minami Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer Eur J Cardiothorac Surg 42 2012 89 92
8. S.A. Carrillo, V.C. Daniel, N. Hall, C.L. Hitchcock, P. Ross Jr., and E.S. Kassis Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer Ann Thorac Surg 93 2012 1621 1624
9. W.Y. Lin, W.H. Hsu, K.H. Lin, and S.J. Wang Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer J Chin Med Assoc 75 2012 203 208
10. N. Ceylan, S. Doʇan, K. Kocaçelebi, R. Savaş, A. Çakan, and U. Çaʇrici Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer Diagn Interv Radiol 18 2012 435 440
11. C. Turkmen, K. Sonmezoglu, and A. Toker The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high Clin Nucl Med 32 2007 607 612
12. M. Nakagawa, M. Hara, and K. Sakurai Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer Acta Radiol 50 2009 638 644
13. A. Ebihara, H. Nomori, and K. Watanabe Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients Jpn J Clin Oncol 36 2006 694 698
14. R.J. Cerfolio, B. Ojha, and A.S. Bryant The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer Ann Thorac Surg 78 2004 1017 1023 discussion 1017-23
15. G. Halter, A.K. Buck, and H. Schirrmeister Lymph node staging in lung cancer using [18F]FDG-PET Thorac Cardiovasc Surg 52 2004 96 101
16. A. Gomez-Caro, S. Garcia, and N. Reguart Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan Eur J Cardiothorac Surg 37 2010 1168 1174
17. M. Tsuboi, T. Ohira, and H. Saji The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer Ann Thorac Cardiovasc Surg 13 2007 73 77
18. G.M. Strauss Adjuvant vs neoadjuvant chemotherapy in resectable NSCLC: is that the real question? Oncology 23 2009 534 536 538
19. J. Wang, K. Welch, L. Wang, and F.M. Kong Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis Clin Lung Cancer 13 2012 81 89
20. M.S. Hofman, N.C. Smeeton, S.C. Rankin, T. Nunan, and M.J. O'Doherty Observer variation in FDG PET-CT for staging of non-small-cell lung carcinoma Eur J Nucl Med Mol Imaging 36 2009 194 199
21. A. Ernst, R. Eberhardt, M. Krasnik, and F.J. Herth Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer J Thorac Oncol 4 2009 947 950
22. T. Nakajima, K. Yasufuku, and M. Nakajima Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment J Thorac Oncol 5 2010 606 611
23. I.I. Na, G.J. Cheon, and D.H. Choe Clinical significance of (18)F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer: a retrospective study Lung Cancer 60 2008 69 74
24. S. Barnett, J.M. Baste, and K. Murugappan Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-(18)F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging Eur J Cardiothorac Surg 39 2011 96 101